Neodynamics
0,449 SEK -1,21 %HC Andersen Capital modtager betaling fra Neodynamics for en Digital IR/Corporate Visibility abonnementsaftale. Læs mere her.
6 investorer følger denne virksomhed
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Omsætning
140 t
EBIT %
-52.307,14 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NEOD
Daglig lav / høj pris
0,42 / 0,48
SEK
Markedsværdi
54,11 mio. SEK
Aktieomsætning
224,94 t SEK
Volumen
503 t
Analyst

Claus Thestrup
CEO, Sweden
Seneste videoer
Finanskalender
Delårsrapport
17.08.2023
Delårsrapport
16.11.2023
Årsrapport
16.02.2024
Forum opdateringer
Viser Alle indholdstyper